These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells. Wiese M; Hamdan FH; Kubiak K; Diederichs C; Gielen GH; Nussbaumer G; Carcaboso AM; Hulleman E; Johnsen SA; Kramm CM Cell Death Dis; 2020 Aug; 11(8):673. PubMed ID: 32826850 [TBL] [Abstract][Full Text] [Related]
4. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Verfaillie A; Imrichova H; Atak ZK; Dewaele M; Rambow F; Hulselmans G; Christiaens V; Svetlichnyy D; Luciani F; Van den Mooter L; Claerhout S; Fiers M; Journe F; Ghanem GE; Herrmann C; Halder G; Marine JC; Aerts S Nat Commun; 2015 Apr; 6():6683. PubMed ID: 25865119 [TBL] [Abstract][Full Text] [Related]
5. Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth. Ghislin S; Deshayes F; Lauriol J; Middendorp S; Martins I; Al-Daccak R; Alcaide-Loridan C Melanoma Res; 2012 Jun; 22(3):184-94. PubMed ID: 22454190 [TBL] [Abstract][Full Text] [Related]
6. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP. Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801 [TBL] [Abstract][Full Text] [Related]
7. Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Ott CJ; Federation AJ; Schwartz LS; Kasar S; Klitgaard JL; Lenci R; Li Q; Lawlor M; Fernandes SM; Souza A; Polaski D; Gadi D; Freedman ML; Brown JR; Bradner JE Cancer Cell; 2018 Dec; 34(6):982-995.e7. PubMed ID: 30503705 [TBL] [Abstract][Full Text] [Related]
8. Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1. Tomazou EM; Sheffield NC; Schmidl C; Schuster M; Schönegger A; Datlinger P; Kubicek S; Bock C; Kovar H Cell Rep; 2015 Feb; 10(7):1082-95. PubMed ID: 25704812 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets. Bacabac M; Xu W Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907 [TBL] [Abstract][Full Text] [Related]
10. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer. Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154 [TBL] [Abstract][Full Text] [Related]
11. HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers. Di Giorgio E; Paluvai H; Dalla E; Ranzino L; Renzini A; Moresi V; Minisini M; Picco R; Brancolini C Genome Biol; 2021 May; 22(1):129. PubMed ID: 33966634 [TBL] [Abstract][Full Text] [Related]
12. Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells. Knappe N; Novak D; Weina K; Bernhardt M; Reith M; Larribere L; Hölzel M; Tüting T; Gebhardt C; Umansky V; Utikal J Stem Cells; 2016 Apr; 34(4):832-46. PubMed ID: 26753613 [TBL] [Abstract][Full Text] [Related]
13. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300. Kim HJ; Moon SJ; Hong S; Won HH; Kim JH Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional Activation of Ecdysone-Responsive Genes Requires H3K27 Acetylation at Enhancers. Cheng D; Dong Z; Lin P; Shen G; Xia Q Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142704 [TBL] [Abstract][Full Text] [Related]
15. NFATc2 is an intrinsic regulator of melanoma dedifferentiation. Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4. Diener J; Baggiolini A; Pernebrink M; Dalcher D; Lerra L; Cheng PF; Varum S; Häusel J; Stierli S; Treier M; Studer L; Basler K; Levesque MP; Dummer R; Santoro R; Cantù C; Sommer L Nat Commun; 2021 Aug; 12(1):5056. PubMed ID: 34417458 [TBL] [Abstract][Full Text] [Related]
17. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells. Caslini C; Hong S; Ban YJ; Chen XS; Ince TA Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747 [TBL] [Abstract][Full Text] [Related]
18. The CaMV 35S enhancer has a function to change the histone modification state at insertion loci in Arabidopsis thaliana. Chen X; Huang H; Xu L J Plant Res; 2013 Nov; 126(6):841-6. PubMed ID: 23880941 [TBL] [Abstract][Full Text] [Related]
19. Histone H4 asymmetrically dimethylated at arginine 3 (H4R3me2a), a mark of super-enhancers. Sudhakar SRN; Wu L; Patel S; Zovoilis A; Davie JR Biochem Cell Biol; 2024 Apr; 102(2):145-158. PubMed ID: 38011682 [TBL] [Abstract][Full Text] [Related]